Additional European Equity News

Aegon (AGN NA) - Co. appoints Jennifer Palmieri as Chief Human Resources Officer. (Aegon)     AstraZeneca (AZN LN) - Co. to showcase Phase III data in liver, breast and bladder cancers and potential first-in-class rare disease therapy at ASCO 2026. EMERALD-3 late-breaking presentation will showcase benefit of Imfinzi and Imjudo in early liver cancer. (AstraZeneca)     BASF (BAS GY) - Co. said Weidmüller is using its Ultramid Advanced N3U41 G6 polyphthalamide in OMNIMATE 4.0 PCB connectors and terminals, citing colourability, chemical resistance, dimensional stability and high temperature resistance for reflow soldering. (BASF) Bouygues (EN FP) -  Equans announces completion of the sale of its EV charging concessions in the Netherlands. (Bouygues)     Games Workshop (GAW LN) - FY26 Trading Update (GBP): Estimates core revenue not less than 625mln (prev. 565mln Y/Y), licensing revenue not less than 30mln (prev. 52.5mln Y/Y), PBT not less than 265mln (prev. 262.8mln Y/Y). (Games Workshop)Inchcape (INCH LN) - Co. agrees to buy Silver Star in Bulgaria, expected to be completed in Q3'26; terms not disclosed. (Inchcape)SBB (SBBB SS) - SBB divests elderly care property in Strängnäs; transaction exp. to complete in June 2026. (SBB)Softcat (SCT LN) - Q3 Trading Update: Guides FY underlying operating profit in the "mid-teens" (prev. guided "high single-digit"). (Softcat)UBS Group (UBSG SW) - UBS accused the ombudsman overseeing a probe into Credit Suisse's handling of Nazi-linked accounts of bias and exceeding his mandate, deepening a standoff with the Senate Judiciary Committee, Bloomberg reports. The bank said it has provided more than 48mln pages of documents, and spent over USD 250mln on the probes, but is withholding more than 27,000 pages it deems legally privileged. The ombudsman countered that UBS was making false and misleading statements, and that his investigation cannot be considered complete until he sees the withheld materials. (Bloomberg)